Yuri Vladimirovich Miroshnichenko

Yuri Vladimirovich Miroshnichenko

Auto-generated profile, based on publicly available information

Yuri Vladimirovich Miroshnichenko

Saint Petersburg State Chemical and Pharmaceutical University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Closed access
PDF file
YMYuri V. Miroshnichenko
Yuri V. Miroshnichenko
APAlexander B. Perfiliev
Alexander B. Perfiliev
MSMaria P. Shcherba
Maria P. Shcherba
RERimma A. Enikeeva
Rimma A. Enikeeva
DODmitrii V. Ovchinnikov
Dmitrii V. Ovchinnikov
ЩПЩерба Мария Петровна
Щерба Мария Петровна
The main stages of the development of the Russian medical and pharmaceutical industry in 2010 are presented in the context of the dominance of large foreign companies producing medicines and medical devices in the pharmaceutical market. This reflects the political and economic restrictive measures illegally taken against Russia by the European Union, the United States of America, and some other unfriendly countries and has influenced the dynamics of the development of the medical and pharmaceutical industry in our country. To harmonize approaches to the production and quality control of medicines, this paper presents the stages of large-scale reforms on the transition of the Russian pharmaceutical industry to standards of good manufacturing practice and the implementation of state programs aimed at modernizing the industrial segment of the pharmaceutical industry. As part of the improvement of the standardization system of medicines, the study also presents the characteristics of the XIII, XIV, and XV editions of the State Pharmacopoeia of the Russian Federation published during the study period, in the development of which employees of the Military Medical Academy named after S.M. Kirov participated. The role and purpose of the creation of the developed Pharmacopoeia of the Eurasian Economic Union, approved by the Board of the Eurasian Economic Commission, is also reflected in this paper. This article describes the phased implementation of federal target programs, state programs, and other strategic plans and measures of nonfinancial support from the state, which have significantly expanded competencies in the field of development and production of medicines and medical devices and increased their output during the period analyzed. The development of medicines and increasing their production volumes with the help of pharmaceutical clusters, which acted as the “locomotives” of the industry, and various projects in establishing the production of innovative medical products with the help of the Industrial Development Fund, which increased the investment attractiveness of these sectors of the national economic complex, played an important role. The results revealed the essence of the changes concerning the revival of the activities of industrial pharmacies, considering a personalized approach to the treatment of patients. The study also presents an assessment of the Pharmaceutical industry Development Strategy for the period up to 2030.

23 June 2025 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Open access
PDF file
YMYuri V. Miroshnichenko
Yuri V. Miroshnichenko
EAEkaterina Yu. Alexeychuk
Ekaterina Yu. Alexeychuk
RERimma A. Enikeeva
Rimma A. Enikeeva
BACKGROUND: Currently, regarding the continuously rising healthcare expenditures, the search for ways to optimize costs and improve budget spending efficiency is becoming increasingly relevant. Unlike pharmaceuticals mass-produced by chemical and pharmaceutical manufacturers, their pharmacy-compounded counterparts have significant competitive advantages. AIM: The study aimed to assess the advantages of extemporaneous medications over their industrial counterparts using the example of a multidisciplinary medical institution — Pokrovskaya City Hospital (St. Petersburg). METHODS: The study’s theoretical and methodological basis included legislative and regulatory acts governing the circulation of medicines and pharmaceutical activities. This includes compounding and quality control of extemporaneous medications; scientific works on organizing pharmaceutical supply, pharmaceutical technology, and quality control of medicinal products and other scientific, methodological, and reference data on the topic under study; and reporting documentation from Pokrovskaya City Hospital. RESULTS AND DISCUSSION: This study substantiates the significance of certain extemporaneous medications over their industrial equivalents based on the needs of medical institutions. It demonstrates how pharmacy-based compounding contributes to more rational use of financial resources and improved quality of medical care. The study emphasizes that pharmacy compounding should comply with current legislation and regulatory acts governing pharmaceutical activities and be based on clearly defined instructions, protocols, and quality standards. Furthermore, collaboration with regulatory authorities and participation in the pharmacovigilance system ensure that extemporaneous medications meet safety and efficacy requirements. A comprehensive analysis is required to assess the advantages of extemporaneous medications over their industrial counterparts — one that considers the cost of raw materials, pharmaceutical personnel labor, equipment depreciation, and quality control expenses. A crucial factor is comparing the production cost of extemporaneous medications with the prices of industrial equivalents, including logistics, storage, and related expenses. CONCLUSION: Pharmacy compounding is a promising and potentially cost-effective direction, provided that it is implemented with due consideration of all critical factors. Proper planning, quality control, and compliance with legal regulations will enable pharmacies to optimize the healthcare system, reduce medication procurement cost, enhance the flexibility and responsiveness of drug supply, and provide opportunities for individualized dosing and composition adjustments to meet specific patient needs.

1 January 2017 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
JMJu. V. Miroshnichenko
Ju. V. Miroshnichenko
VKV. N. Kononov
V. N. Kononov
ERE. O. Rodionov
E. O. Rodionov
OMO. Z. Mustaev
O. Z. Mustaev
ESE. A. Soldatov
E. A. Soldatov
IKI. V. Klochkova
I. V. Klochkova
ВЛИЯНИЕ ОСОБЫХ МЕДИКО-ГЕОГРАФИЧЕСКИХ УСЛОВИЙ АРКТИКИ НА ОБЕСПЕЧЕНИЕ СОЕДИНЕНИЙ И ВОИНСКИХ ЧАСТЕЙ МЕДИЦИНСКИМ ИМУЩЕСТВОМ

13 July 2023 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Open access
PDF file
YMYuri V. Miroshnichenko
Yuri V. Miroshnichenko
APAlexander B. Perfiliev
Alexander B. Perfiliev
DODmitry V. Ovchinnikov
Dmitry V. Ovchinnikov
NKNatalya L. Kostenko
Natalya L. Kostenko
SBSergey A. Bunin
Sergey A. Bunin
ПБПерфильев Александр Борисович
Перфильев Александр Борисович
This article presents the activities of the medical service in organizing the provision of medical equipment to the troops (forces) of the Russian Federation in the first decade of the 21st century. It reflects the main stages of development of the pharmaceutical industry in the post-default state of the economy and the emergence of new mechanisms and forms of interaction with transnational pharmaceutical companies. The article showcases the positive features and shortcomings of implementing programs for additional drug provision and ensuring the population has access to necessary drugs. Additionally, it discusses the reorganization of the medical service of the Armed Forces of the Russian Federation as part of a large-scale reform of the military organization. The organizational and staffing changes in the military administration of the medical service, pharmaceutical organizations of the Ministry of Defense of the Russian Federation, and medical supply units are represented, highlighting their reorganization and restructuring by the end of the 2000s during the ongoing modernization of the Russian Federation Armed Forces. The article also describes the three-level system of medical supply of troops (forces) that developed after modernization. The leading role of the Department of Military Medical Supply and Pharmacy of the Kirov Military Medical Aca demy and the Center for Pharmacy and Medical Equipment in updating the regulatory legal framework for the medical supply system for troops (forces) is discussed. Their activities of these entities during the modernization of the medical supply system for troops (forces) to create key regulatory legal acts such as orders and directives of the Minister of Defense of the Russian Federation and official documents as part of research work are disclosed. Finally, the article provides a list of normative legal acts and service documents developed during this period, which regulate various aspects of activities related to providing military equipment to the troops (forces) and have been updated and harmonized with the legislation of the Russian Federation, is given.

15 December 2025 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Closed access
PDF file
YMYuri V. Miroshnichenko
Yuri V. Miroshnichenko
EAEkaterina Yu. Alexeichuk
Ekaterina Yu. Alexeichuk
RERimma A. Enikeeva
Rimma A. Enikeeva
BAKGRAUND: Risk management and effective sanitary and anti-epidemic measures are crucial for improving the efficiency of pharmaceutical compounding. Most pharmacies lack a comprehensive and well-defined algorithm for developing sanitary and anti-epidemic requirements or sanitary and hygienic measures in their standard operating procedures or other local policies. AIM: This work aimed to provide a risk-based, research- and practice-oriented approach to developing standard operating procedures and local regulations to improve sanitary and hygienic measures in pharmacies, including those with the right to aseptic pharmaceutical compounding. The work also aimed to propose an algorithm for implementing these measures into routine practice. METHODS: The work was based on laws and regulations on drug circulation and pharmaceutical activities, research into drug provision and sanitary and anti-epidemic measures in pharmacies, as well as other scientific publications and reference materials on the subject. Latent semantic, historical, structural logical, and content analyses were used. RESULTS: Due to the lack of clear requirements for the implementation of sanitary and hygienic measures, the following risks have been identified: reduced quality and safety of pharmaceutical products; contamination of pharmacy facilities (e.g., process equipment) with various agents, including microorganisms. The fundamental principles of sanitary, hygienic, and anti-epidemic measures in pharmacies were justified. The key sanitary requirements for pharmacies were specified, including interior finishing, ventilation, and lighting, as well as receipt, storage, and transportation of purified water and water for injection. Specific sanitary and anti-epidemic measures were defined for pharmaceutical compounding, including aseptic compounding. A recommended schedule for junior pharmacy staff during sanitary and hygienic measures was provided. CONCLUSION: Pharmacies should make the development and implementation of standard operating procedures and local regulations a priority to improve their sanitary and hygienic practices. This will significantly improve the effectiveness of pharmaceutical compounding. A risk-based approach to sanitary and hygienic measures in pharmacies is essential for ensuring the high quality and safety of compounded drug products. Any deviations in this approach can have a detrimental impact on public health.

31 October 2022 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
GYGaleppo Yu.L.
Galeppo Yu.L.
MYMiroshnichenko Yu.V.
Miroshnichenko Yu.V.
Relevance. Currently, more attention is being paid to improving the quality of drug provision for multidisciplinary medical organizations. An objective analysis of factors, including the analysis of the structure of the composition of patients hospitalized in multidisciplinary medical organizations, is of great importance. Aim. To analyze the composition of patients hospitalized in the departments of therapeutic and surgical profile of multidisciplinary medical organizations. Materials and methods. Materials: statistical reports, journals of the movement of medicines and prescribing lists of medical histories of patients examined by multidisciplinary medical organizations, as well as data on standards of medical care and clinical recommendations. Methods: retrospective analysis, methods of comparison, correspondence, etc. Results. This article presents the results of the analysis of the morbidity structure of patients hospitalized in surgical and therapeutic departments of multidisciplinary medical organizations of the research base, which revealed that the most common diseases in these multidisciplinary medical organizations are respiratory diseases (Class X), circulatory system (Class IX) and digestive organs (Class XI). The analysis of the categories of the most common classes of diseases according to ICD-10 in each multidisciplinary medical organization showed the most common nosological forms in each category of ICD-10. For example, in the structure of diseases under the headings of Class I "Infectious and parasitic diseases" in all multidisciplinary medical organizations, the research base showed the predominance of the following nosological forms: chickenpox (B01) and acute intestinal infections caused by unidentified infectious agents (A09). Conclusion. To improve the quality of medical care, special attention should be paid to the compliance of the drug provision of multidisciplinary medical organizations with the structure of the morbidity of patients admitted to it.